ACTIVE | NOSI: Stimulate Research on the Diagnosis, Treatment, and Mechanistic Understanding of Postural Orthostatic Tachycardia Syndrome (POTS) | NOT-HL-24-018 | Vary by IC | 01/08/2028 |
ACTIVE | NOSI: Understanding the Basic Mechanisms of Immune-related Adverse Events (irAEs) in Cancer Immunotherapy | NOT-CA-24-055 | Vary by IC | 11/6/2027 |
| ACTIVE | NOSI: Women’s Health Research | NOT-OD-24-079 | Vary by NIH ICs | 11/5/2027 |
| ACTIVE | NOSI: Autoimmune Inner Ear Disease
(Clinical Trials Not Allowed) | NOT-DC-25-003 | 2/16/2025 | 10/17/2027 |
ACTIVE | NOSI: Systems Modeling of Infection and Immunity Across Biological Scales | NOT-AI-24-060 | Standard NIH Due Dates | 9/8/2027 |
ACTIVE | Examining the Impact of Artificial Intelligence (AI) on Healthcare Safety (R18) | PA-24-261 | Standard NIH Due Dates | 5/26/2027 |
ACTIVE | Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed) | PAR-25-131 | 1/28/2025 | 4/16/2027 |
ACTIVE | NOSI: R13 Support for Conferences and Scientific Meetings to Support Consensus Building for Autoimmune Disease Research Related Common Data Elements | NOT-OD-24-145 | 4/12/2025 | 12/14/2026 |
| ACTIVE | NOSI: Research Supplements to Promote Re-Entry, Re-integration into, and Re-training in Health-Related Research Careers (Admin Supp - Clinical Trial Not Allowed) | NOT-OD-23-170 | Vary by NIH Institutes and Centers (ICs) | 10/9/2026 |
| ACTIVE | NOSI: Research on the Health of Women of Underrepresented, Underserved, and
Underreported (U3) Populations (Admin Supp Clinical Trial Optional) | NOT-OD-24-179 | 1/22/2025
1/22/2026 | 1/23/2026 |
ACTIVE | Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trials Not Allowed) | RFA-ES-25-003 | 2/3/2025 | 12/2/2025 |
| ACTIVE | Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R21 - Clinical Trial Optional) | PAR-25-115 | 2/16/2025 | 11/17/2025 |
| ACTIVE | Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R01 - Clinical Trial Optional) | PAR-25-116 | 2/5/2025 | 11/6/2025 |
ACTIVE | Exploratory/Developmental Research on Guillain Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (R21 - Clinical Trial Not Allowed) | RFA-NS-25-025 | 3/3/2025 | 10/4/2025 |
| ACTIVE | Notice of Intent to Publish a Funding Opportunity Announcement for Complement-ARIE New Approach Methodologies (NAMs) Data Hub and Coordinating Center (U24 Clinical Trial Optional) | NOT-RM-24-015 | Est. Publication Date of NOFO: 11/29/2024 | Est. Application Due Date:
3/10/2025 |
ACTIVE | Complement-ARIE New Approach Methodologies (NAMs) Technology Development Centers (UM1 Clinical Trial Optional) | RFA-RM-24-010 | 2/28/2025 | 3/1/2025 |
CLOSED | Notice of Intent to Publish a Funding Opportunity Announcement for Complement-ARIE New Approach Methodologies (NAMs) Technology Development Centers (UM1 Clinical Trial Optional) | NOT-RM-24-012 | Est. NOFO Publication Date: 10/18/2024 | Est. Application Due Date: 2/28/2025 |
| CLOSED | Environmental Health Disparities Centers (P50) Clinical Trial Optional | RFA-MD-24-010 | 12/5/2024 | 12/6/2024 |
| CLOSED | Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R01 Clinical Trial Not Allowed) | RFA-DE-25-001 | 11/19/2024 | 11/20/2024 |
| CLOSED | Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R21 Clinical Trial Not Allowed) | RFA-DE-25-002 | 11/19/2024 | 11/20/2024 |
CLOSED | HEAL Initiative: HEAL KIDS (Knowledge, Innovation and Discovery Studies): Chronic Pain Program (UC2 Clinical Trial Optional) | RFA-AR-24-007 | 11/8/2024 | 11/9/2024 |
CLOSED | Notice of Intent to Publish a Funding Opportunity Announcement for Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R01 - Clinical Trial Optional) | NOT-NS-24-105 | Est. NOFO Publication Date: 10/28/2024 | Est. Application Due Date:
2/3/2025 |
CLOSED | Notice of Intent to Publish a Funding Opportunity Announcement for Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R21 - Clinical Trial Optional) | NOT-NS-24-108 | Est. NOFO Publication Date: 10/28/2024 | Est. Application Due Date:
2/3/2025 |
CLOSED | RADx® Tech ACT ENDO Challenge Advancing Cures and Therapies and ending ENDOmetriosis diagnostic delays (ACT ENDO) Challenge | - | Phase I:
10/11/2024 | - |
CLOSED | RFI: Evolving the Network of the National Library of Medicine (nih.gov) | NOT-LM-24-001 | 8/30/2024 | 8/30/2024 |
| CLOSED | Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) | PAR-24-206 | 8/13/2024 | 8/14/2024 |
CLOSED | RFI: NIH Common Fund is Soliciting Ideas for NIH-wide Challenges and Opportunities | NOT-RM-24-010 | 8/10/2024 | 8/10/2024 |
| CLOSED | Understanding Chronic Conditions Understudied Among Women (R21 Clinical Trial Optional) | RFA-OD-23-013 | 6/20/2024 | 6/21/2024 |
| CLOSED | Understanding Chronic Conditions Understudied Among Women (R01 Clinical Trial Optional) | RFA-OD-23-014 | 6/20/2024 | 6/21/2024 |
| CLOSED | RFI: Proposed Use of Common Data Elements (CDEs) for NIH-Funded Clinical Research and Trials | NOT-OD-24-063 | 4/20/2024 | 4/20/2024 |
| CLOSED | Team Science Leadership Scholars Program (LSP) in Women’s Health, Autoimmune and Immune-Mediated Diseases 2.0 | RFA-AMPAIM-LSP-23-002 | 4/1/2024 | 4/1/2024 |
| CLOSED | RFI: Inviting Input on an NIH-Wide Strategic Plan for Autoimmune Disease Research | NOT-OD-24-049 | 3/1/2024 | 3/1/2024 |
| CLOSED | NOSI: Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional) | NOT-OD-24-032 | 1/31/2024 | 2/1/2024 |
| CLOSED | NOSI: EXposome in Autoimmune Disease Collaborating Teams PLANning Awards (EXACT-PLAN) (Clinical Trials Not Allowed) | NOT-OD-23-112 | 6/16/2023 | 6/17/2023 |
